Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-47309

Single-particle
2.67 Å
EMD-47309
3D View Gallery
Deposition: 14/10/2024
Map released: 08/01/2025
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47309
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9dym summary report (pdf.gz) Map and 9dym FULL report (pdf.gz)
EMICSS annotations (xml)

BEST1 + PABA intermediate state

EMD-47309

Single-particle
2.67 Å
EMD-47309
3D View Gallery
Deposition: 14/10/2024
Map released: 08/01/2025
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: BEST1 + PABA intermediate state
Fitted models: 9dym

Deposition Authors: Owji AP, Kittredge A , Zhang Y , Yang T
Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment.
Owji AP, Dong J, Kittredge A , Wang J , Zhang Y , Yang T
(2024) Nat Commun , 15 , 10766 - 10766
PUBMED: 39737942
DOI: doi:10.1038/s41467-024-54938-z
ISSN: 2041-1723